We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.65B
1-Year Est. Return
203.21%
This Fund
S&P 500
This Quarter
Est. Return
+18.27%
1 Year Est. Return
+203.21%
3 Year Est. Return
+364.25%
5 Year Est. Return
+595.91%
10 Year Est. Return
+10,683%
AUM
$1.08B
AUM Growth
+$89.3M
(+9%)
Cap. Flow
+$8.65M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
53.14%
Holding
94
New
23
Increased
12
Reduced
34
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$34.7M |
| 2 |
SCTL
Societal CDMO, Inc. Common Stock
SCTL
|
+$13.5M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$11.4M |
| 4 |
Guardant Health
GH
|
+$9.37M |
| 5 |
SONX
Sonendo, Inc.
SONX
|
+$7.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
+$12.5M |
| 2 |
MODN
MODEL N, INC.
MODN
|
+$12.3M |
| 3 |
Mirum Pharmaceuticals
MIRM
|
+$11M |
| 4 |
CareDx
CDNA
|
+$9.36M |
| 5 |
CUTR
Cutera, Inc.
CUTR
|
+$8.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 91.34% |
| 2 | Communication Services | 8.59% |
| 3 | Miscellaneous | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
26
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $15.6M | 1.45% |
+137,077
| New | +$11.4M |
|
27
Insmed
INSM
$26.2B
| $15M | 1.39% |
748,970
-7,447
| -1% | -$144K |
|
|
SCTL
28
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $12.8M | 1.19% |
+8,571,870
| New | +$13.5M |
|
29
BioMarin Pharmaceuticals
BMRN
$12.5B
| $12.5M | 1.16% |
120,941
-2,381
| -2% | -$224K |
|
30
Health Catalyst
HCAT
$129M
| $12.4M | 1.15% |
1,161,995
+12,162
| +1% | +$117K |
|
31
OrthoPediatrics
KIDS
$607M
| $12M | 1.12% |
302,731
-5,997
| -2% | -$250K |
|
|
SONX
32
DELISTED
Sonendo, Inc.
SONX
| $11.8M | 1.1% |
4,185,619
+3,962,226
| +1,774% | +$7.47M |
|
33
Ultragenyx Pharmaceutical
RARE
$1.29B
| $10.9M | 1.01% |
234,299
-219,495
| -48% | -$8.63M |
|
34
MaxCyte
MXCT
$123M
| $7.45M | 0.69% |
1,365,343
+2,800
| +0.2% | +$17.2K |
|
35
Pfizer
PFE
$157B
| $7.26M | 0.67% |
141,761
-5,390
| -4% | -$258K |
|
36
Genmab
GMAB
$21B
| $6.79M | 0.63% |
160,263
-1,464
| -0.9% | -$60.3K |
|
37
OptimizeRx
OPRX
$142M
| $6.07M | 0.56% |
361,276
-2,760
| -0.8% | -$47.7K |
|
|
ABCM
38
DELISTED
Abcam PLC
ABCM
| $5.91M | 0.55% |
379,634
-3,923
| -1% | -$61.3K |
|
|
39
Guardant Health
GH
$23.6B
| $5.57M | 0.52% |
+204,804
| New | +$9.37M |
|
40
Castle Biosciences
CSTL
$1.08B
| $3.8M | 0.35% |
161,604
-1,620
| -1% | -$37.6K |
|
41
Bioventus
BVS
$888M
| $3.59M | 0.33% |
1,376,536
-22,386
| -2% | -$97.7K |
|
|
AKU
42
DELISTED
Akumin Inc
AKU
| $2.56M | 0.24% |
3,564,264
-200,000
| -5% | -$269K |
|
|
MIRO
43
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
| $1.6M | 0.15% |
534,656
+18,649
| +4% | +$73.2K |
|
44
Simulations Plus
SLP
$372M
| $1.31M | 0.12% |
35,753
-308
| -0.9% | -$13K |
|
45
iShares Russell 2000 Growth ETF
IWO
$14.1B
| $734K | 0.07% |
+3,422
| New | +$750K |
|
46
Humana
HUM
$47.6B
| $455K | 0.04% |
888
-180
| -17% | -$94.6K |
|
47
Elevance Health
ELV
$90.6B
| $454K | 0.04% |
886
-358
| -29% | -$182K |
|
48
Centene
CNC
$33.4B
| $453K | 0.04% |
+5,521
| New | +$451K |
|
49
Integra LifeSciences
IART
$1.22B
| $407K | 0.04% |
+7,261
| New | +$370K |
|
50
Smith & Nephew
SNN
$11.7B
| $406K | 0.04% |
+15,111
| New | +$379K |
|
Similar funds
AAM
NPA
SOS
BCM
BFO
AAG
MCIL
TIM
First Light Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, First Light Asset Management held 94 positions worth $1.08B, up 9% from $988M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
First Light Asset Management's Q4 2022 filing shows 23 new, 12 increased, 34 reduced and 20 closed positions. Its largest new stake was Societal CDMO, Inc. Common Stock: 8,571,870 shares worth $12.8M. The largest sale was NGM Biopharmaceuticals, Inc. Common Stock, an estimated $12.5M.
By sector, the portfolio is most concentrated in Healthcare at 91% of assets, up from 90% a quarter earlier, followed by Communication Services and Miscellaneous.
- First Light Asset Management's largest Q4 2022 buy was Societal CDMO, Inc. Common Stock: 8,571,870 shares worth $12.8M.
- First Light Asset Management added most to Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2022, an estimated $34.7M increase.
- First Light Asset Management's biggest Q4 2022 reduction was MODEL N, INC., cutting an estimated $12.3M.
- First Light Asset Management fully exited NGM Biopharmaceuticals, Inc. Common Stock in Q4 2022, selling an estimated $12.5M.
- First Light Asset Management's ten largest holdings make up 53% of its $1.08B portfolio in Q4 2022.
- First Light Asset Management opened 23 new positions and closed 20 in Q4 2022.
- First Light Asset Management's portfolio value rose 9% quarter-over-quarter to $1.08B.
Based on First Light Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.